Live Breaking News & Updates on Surya Bhatt

Stay updated with breaking news from Surya bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pulmonology Month in Review: May 2024

This review of May 2024 covered several notable topics in the pulmonary health field, including research into vaping, lung abnormalities, and treatment of COPD.
....

United States , Andrew Kochvar , Surya Bhatt , Nancy Rigotti , Bina Choi , University Of Alabama At Birmingham , Medicine At Harvard Medical School , University Of Nebraska Medical Center , Drug Administration , Tobacco Research , Division Of Pulmonary , Treatment Center At Massachusetts , American Thoracic Society International Conference , Regeneron Pharmaceutical , Biologic License Application , Thoracic Society International , Critical Care Medicine , Treatment Center , Massachusetts General Hospital , Harvard Medical , Nebraska Medical Center ,

Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results

Surya Bhatt, MD, MSPH, of the University of Alabama at Birmingham, discussed the challenges of diagnosing chronic obstructive pulmonary disease (COPD) with type 2 inflammation, as well as the promising efficacy of dupilumab in treating this condition. ....

United States , Surya Bhatt , Physiology Lab , American Thoracic Society , International Conference , University Of Alabama At Birmingham , Pulmonary Function , Exercise Physiology Lab ,

FDA Extends Dupilumab COPD Decision to September 2024

The FDA moved the target date for their decision on the dupilumab application by 3 months, citing a need for more efficacy data from its pivotal phase 3 trials. ....

Surya Bhatt , Smitht Surya Bhatt , Lung Imaging Lab , University Of Alabama At Birmingham , Drug Administration , Regeneron Pharmaceutical , Biologic License Application , European Medicines Agency , Medicinal Products , Human Use , Published February ,

Sanofi/Regeneron's Dupixent recommended by CHMP for uncontrolled COPD

Sanofi/Regeneron's Dupixent recommended by CHMP for uncontrolled COPD
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Surya Bhatt , Regeneron Dupixent , University Of Alabama At Birmingham , European Commission , European Medicines Agency , Committee For Medicinal Products Human Use , Medicinal Products , Human Use ,

Late-Breaking Data From Clinical Trials Show Promise for the Future of COPD Treatment

Study authors shared late-breaking data in a session on clinical trial results in pulmonary medicine at the American Thoracic Society 2024 International Conference. ....

National Jewish Health , United States , South Korea , Charlesl Daley , Dave Singh , Surya Bhatt , University Of Alabama At Birmingham , University Of Manchester , Division Of Pulmonary , American Thoracic Society , Manchester University , International Conference , University Of Colorado School Medicine , Clinical Trial Results , Image Credit , Highlights Efficacy , Treating Mycobacterium Avium Complex Lung , Colorado School , Life Bronchiectasis Respiratory Domain , Patient Global Impression , Shows Promise , Respiratory Questionnaire , Significantly Reduces Exacerbations , Findings From , Critical Care Medicine ,